Xencor, Inc. (XNCR)

34.05 -0.98 (-2.80%) USD  |  NASDAQ  |  Nov 05, 16:00
34.04 0.00 (0.00%) After-Hours: 20:00
More

Xencor SG&A Expense (TTM) : 51.13M for Sept. 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 51.13M
June 30, 2026 65.28M
March 31, 2026 64.02M
December 31, 2025 63.64M
September 30, 2025 61.52M
June 30, 2025 62.13M
March 31, 2025 64.76M
December 31, 2024 61.22M
September 30, 2024 61.57M
June 30, 2024 59.30M
March 31, 2024 53.01M
December 31, 2023 53.17M
September 30, 2023 50.65M
June 30, 2023 50.53M
March 31, 2023 50.16M
December 31, 2022 47.49M
September 30, 2022 46.11M
June 30, 2022 44.11M
March 31, 2022 41.88M
December 31, 2021 38.84M
September 30, 2021 35.06M
June 30, 2021 32.33M
March 31, 2021 30.70M
December 31, 2020 29.69M
September 30, 2020 28.84M
Date Value
June 30, 2020 27.46M
March 31, 2020 25.99M
December 31, 2019 24.28M
September 30, 2019 23.05M
June 30, 2019 24.22M
March 31, 2019 23.42M
December 31, 2018 22.47M
September 30, 2018 21.38M
June 30, 2018 18.12M
March 31, 2018 17.25M
December 31, 2017 17.50M
September 30, 2017 16.18M
June 30, 2017 15.02M
March 31, 2017 13.97M
December 31, 2016 13.11M
September 30, 2016 13.44M
June 30, 2016 13.66M
March 31, 2016 13.15M
December 31, 2015 11.96M
September 30, 2015 10.48M
June 30, 2015 9.432M
March 31, 2015 8.502M
December 31, 2014 7.461M
September 30, 2014 6.809M
June 30, 2014 5.469M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 64.55M
UroGen Pharma Ltd. 139.27M
MeiraGTx Holdings Plc 52.16M
IDEAYA Biosciences, Inc. 60.68M
Iovance Biotherapeutics, Inc. 114.62M